| Environment drives selection and function of enhancers controlling tissue-specific macrophage identities D Gosselin, VM Link, CE Romanoski, GJ Fonseca, DZ Eichenfield, ... Cell 159 (6), 1327-1340, 2014 | 1294 | 2014 |
| Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines KB Glaser, MJ Staver, JF Waring, J Stender, RG Ulrich, SK Davidsen Molecular cancer therapeutics 2 (2), 151-163, 2003 | 719 | 2003 |
| Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription MU Kaikkonen, NJ Spann, S Heinz, CE Romanoski, KA Allison, ... Molecular cell 51 (3), 310-325, 2013 | 701 | 2013 |
| Genome-wide analysis of estrogen receptor α DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation JD Stender, K Kim, TH Charn, B Komm, KCN Chang, WL Kraus, C Benner, ... Molecular and cellular biology, 2010 | 252 | 2010 |
| Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20 JD Stender, G Pascual, W Liu, MU Kaikkonen, K Do, NJ Spann, M Boutros, ... Molecular cell 48 (1), 28-38, 2012 | 240 | 2012 |
| 53BP1 and USP28 mediate p53 activation and G1 arrest after centrosome loss or extended mitotic duration F Meitinger, JV Anzola, M Kaulich, A Richardson, JD Stender, C Benner, ... Journal of Cell Biology 214 (2), 155-166, 2016 | 211 | 2016 |
| Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation JD Stender, J Frasor, B Komm, KCN Chang, WL Kraus, ... Molecular Endocrinology 21 (9), 2112-2123, 2007 | 153 | 2007 |
| Structural and molecular mechanisms of cytokine-mediated endocrine resistance in human breast cancer cells JD Stender, JC Nwachukwu, I Kastrati, Y Kim, T Strid, M Yakir, ... Molecular cell 65 (6), 1122-1135. e5, 2017 | 109 | 2017 |
| Conserved role for autophagy in Rho1-mediated cortical remodeling and blood cell recruitment P Kadandale, JD Stender, CK Glass, AA Kiger Proceedings of the National Academy of Sciences 107 (23), 10502-10507, 2010 | 80 | 2010 |
| Selective recognition of distinct classes of coactivators by a ligand-inducible activation domain ML Acevedo, KC Lee, JD Stender, BS Katzenellenbogen, WL Kraus Molecular cell 13 (5), 725-738, 2004 | 70 | 2004 |
| NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms J Frasor, L El-Shennawy, JD Stender, I Kastrati Molecular and cellular endocrinology 418, 235-239, 2015 | 61 | 2015 |
| Diverse motif ensembles specify non-redundant DNA binding activities of AP-1 family members in macrophages GJ Fonseca, J Tao, EM Westin, SH Duttke, NJ Spann, T Strid, Z Shen, ... Nature communications 10 (1), 414, 2019 | 60 | 2019 |
| OCT-4: A novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells S Bhatt, JD Stender, S Joshi, G Wu, BS Katzenellenbogen Oncogene 35 (44), 5722-5734, 2016 | 53 | 2016 |
| Epigenomic control of the innate immune response JD Stender, CK Glass Current opinion in pharmacology 13 (4), 582-587, 2013 | 46 | 2013 |
| The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers I Kastrati, SEP Joosten, SE Semina, LH Alejo, SD Brovkovych, JD Stender, ... Molecular Cancer Research 18 (7), 1018-1027, 2020 | 35 | 2020 |
| A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction TE Speltz, JM Danes, JD Stender, J Frasor, TW Moore ACS chemical biology 13 (3), 676-684, 2018 | 31 | 2018 |
| Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output G Reyes, M Niederst, K Cohen-Katsenelson, JD Stender, MT Kunkel, ... Proceedings of the National Academy of Sciences 111 (38), E3957-E3965, 2014 | 30 | 2014 |
| The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells JD Stender, F Stossi, CC Funk, TH Charn, DH Barnett, ... Molecular Endocrinology 25 (10), 1699-1709, 2011 | 29 | 2011 |
| PHLPP1 counter-regulates STAT1-mediated inflammatory signaling K Cohen Katsenelson, JD Stender, AT Kawashima, G Lorden, ... Elife 8, e48609, 2019 | 27 | 2019 |
| RANK ligand converts the NCoR/HDAC3 co-repressor to a PGC1β-and RNA-dependent co-activator of osteoclast gene expression Y Abe, ER Kofman, M Almeida, Z Ouyang, F Ponte, JR Mueller, ... Molecular Cell 83 (19), 3421-3437. e11, 2023 | 3 | 2023 |
Erica StoneAssistant Professor, The Wistar Institute
